Opto Circuits (India) Ltd. (BSE:532391) said the Cardiac Sciences business it bought back in 2010 won a $23 million victory over Zoll Medical in a breach of contract lawsuit. A jury in the Los Angeles Superior Court last month awarded Cardiac Sciences $23.0 million in lost royalties, stemming from a 2002 licensing agreement with LifeCor for patents […]
Opto Circuits Ltd.
Aptus Endosystems lands FDA nod for abdominal aneurysm device
Stents: Medtronic’s subclavian approach for valve-replacement device achieved “excellent” results in clinical trial | PCR 2011 Roundup
India’s Opto Circuits closes Cardiac Science buyout
Opto Circuits (India) Ltd. (BSE:532391) closed its short-form merger with Cardiac Science Corp. (NSDQ:CSCX).
The Bangalore, India-based medical device developer acquired Cardiac Science in two steps: An all-cash tender offer for $2.30 per share, under which it bought a 77 percent stake; and a short-form merger by which it snapped up enough of the remaining shares to forego stockholders’ formal approval under Delaware law.
